OPS
MDGL icon

Orion Portfolio Solutions’s Madrigal Pharmaceuticals MDGL Stock Holding History

Orion Portfolio Solutions’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.19M Buy
3,591
+497
+16% +$163K 0.01% 990
2024
Q4 		$955K Sell
3,094
-90
-3% -$25.3K 0.01% 1080
2024
Q3 		$676K Sell
3,184
-293
-8% -$75K 0.01% 1216
2024
Q2 		$974K Buy
+3,477
New +$828K 0.01% 1007

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Orion Portfolio Solutions's MDGL Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Madrigal Pharmaceuticals (MDGL) stake by 16% in Q1 2025, buying an estimated $163K and bringing the position to 3,591 shares worth $1.19M. The position accounts for 0.01% of the portfolio, ranked #990.

Orion Portfolio Solutions first reported a position in MDGL in Q2 2024 and has held it in 4 quarters since. 321 funds tracked by Wall St. Rank hold MDGL as of Q1 2025.

  • Orion Portfolio Solutions held 3,591 shares of Madrigal Pharmaceuticals worth $1.19M as of Q1 2025.
  • Orion Portfolio Solutions bought 497 Madrigal Pharmaceuticals shares in Q1 2025, an estimated $163K.
  • Madrigal Pharmaceuticals made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #990 holding.
  • Orion Portfolio Solutions first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • 321 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.